Recent News

AZ’ Lynparza hits targets in ovarian cancer trial

AstraZeneca has unveiled data from a late-stage trial showing that Lynparza improved progression free survival (PFS) in patients with a certain form of ovarian cancer when used in the maintenance setting.

AstraZeneca

Original Link...


Tags: medical, MEDICINE, pharmaceuticals
0 Volde
Report        

Read On: